Cytokinetics Inc. buy Needham & Company LLC
Start price
20.10.23
/
50%
€31.40
Target price
20.10.24
€56.68
Performance (%)
67.20%
Price
10:35
€53.00
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL for Cytokinetics Inc. has seen massive gains of 67.20%. This prediction currently runs until 20.10.24. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytokinetics Inc. | 0.000% | 0.000% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $60.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Needham___Company_LL for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€40.60
01.03.23
01.03.23
€54.33
01.03.24
01.03.24
63.79%
02.03.24
02.03.24